This article presents guidelines on the diagnosis and management of advanced stage lung cancer developed by the ESMO in 2013.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung - Cancer
July 26, 2014
This article summarizes consensus guidelines for the diagnosis and management of early stage lung cancer developed by ESMO in 2013.
July 12, 2014
This editorial, authored by a number of presidents/leaders of prominent medical societies, laments a recent position paper of the ESMO espousing medical oncologists as the natural team leaders of multidisciplinary oncologic care. It cautions other cancer specialists not to abandon their roles as advocates for their cancer patients.
July 8, 2014
Stephanie Worrel discusses the use of lobectomy in lung cancer patients over 75 years old, and the impact robotic lobectomy has on outcomes.
July 1, 2014
This single institution retrospective study compared outcomes for lobectomy and segmentectomy using propensity score matching. For 312 pts in each group, there was no difference in logoregional or overall recurrence rates. Operative mortality rates were similar for segmentectomy and lobectomy (1.2% vs 2.5%). 5-year surival rates were also similar
July 1, 2014
This randomized trial of high risk patients with small clinial stage I cancers randomized pts to sublobar resection with or without adjuvant brachytherapy. The median follow-up for 222 pts was 4.4 years. 3 year survival was identical (71%) between the groups. There was no difference in time to local recurrence. Brachytherapy did not significantly
June 30, 2014
Shanda Blackmon, Daniel Boffa, Farhood Farjah, and Gaetano Rocco discuss lung cancer screening at the 2014 STS Annual Meeting.
June 26, 2014
Joseph Shrager, Chief of the Stanford Division of Thoracic Surgery, discusses the process of establishing a lung cancer screening program.
June 26, 2014
Although lung cancer is common in the elderly population, little information specific to this population is available to inform healthcare practitioners. The EORTC, in collaboration with the International Society of Geriatric Oncology, released a concensus statement in 2010 on this topic. Since then a number of related studies have been published.
June 25, 2014
In this study presented by Dr. Joshua A. Roth recently at the ASCO meeting, they used a model to forecast the 5-year results of implementation of a screening program (as suggest the NLST, age older than 55 with at least 30 pack-years of smoking history) in comparison to no screening program.